654 results on '"Nault, Isabelle"'
Search Results
2. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
3. Ventricular Tachycardia and ICD Therapy Burden With Catheter Ablation Versus Escalated Antiarrhythmic Drug Therapy
4. Cost-effectiveness of atrial fibrillation screening in Canadian community practice
5. Rationale and Design of the Randomized Bayesian Multicenter COME-TAVI Trial in Patients With a New Onset Left Bundle Branch Block
6. Air Pollution and Arrhythmias
7. Characterization of arrhythmia substrate to ablate persistent atrial fibrillation (COAST-AF): Randomized controlled trial design and rationale
8. Incidence and clinical impact of tachyarrhythmic events following transcatheter aortic valve replacement: A review
9. Evaluation of Saline-Enhanced Radiofrequency Needle-Tip Ablation for Ventricular Tachycardia (SERF VT CANADA Trial)
10. Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study
11. Evolution of Devices to Prevent Sudden Cardiac Death: Contemporary Clinical Impacts
12. Ablation of Refractory Ventricular Tachycardia Using Intramyocardial Needle Delivered Heated Saline-Enhanced Radiofrequency Energy: a First-in-Man Feasibility Trial
13. Ambulatory Electrocardiogram Monitoring in Patients Undergoing Transcatheter Aortic Valve Replacement: JACC State-of-the-Art Review
14. Driving Restrictions and Early Arrhythmias in Patients Receiving a Secondary Prevention Implantable Cardioverter-Defibrillator (DREAM-ICD- II study)
15. Pulmonary Vein Stenosis After Atrial Fibrillation Ablation: Insights From the ADVICE Trial
16. 3D Mapping and Reduction in Radiation Exposure
17. Prolonged Continuous Electrocardiographic Monitoring Prior to Transcatheter Aortic Valve Replacement: The PARE Study
18. Driving Restrictions and Early Arrhythmias in Patients Receiving a Primary-Prevention Implantable Cardioverter-Defibrillator (DREAM-ICD) Study
19. Impact of Female Sex on Clinical Presentation and Ablation Outcomes in the CIRCA-DOSE Study
20. 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Position Statement on the Management of Ventricular Tachycardia and Fibrillation in Patients With Structural Heart Disease
21. The role of brain natriuretic peptide in atrial fibrillation: a substudy of the Substrate Modification with Aggressive Blood Pressure Control for Atrial Fibrillation (SMAC-AF) trial
22. Blinded Randomized Trial of Anticoagulation to Prevent Ischemic Stroke and Neurocognitive Impairment in Atrial Fibrillation (BRAIN-AF): Methods and Design
23. Pattern of Atrial Fibrillation and Cognitive Function in Young Patients With Atrial Fibrillation and Low CHADS2 Score: Insights From the BRAIN-AF Trial
24. TCT-103 Silent New-Onset Atrial Fibrillation After Transcatheter Aortic Valve Replacement
25. Prognostic Value of Noninducibility on Outcomes of Ventricular Tachycardia Ablation: A VANISH Substudy
26. Cost Effectiveness of Ventricular Tachycardia Ablation Versus Escalation of Antiarrhythmic Drug Therapy: The VANISH Trial
27. Abstract 13461: Longitudinal Evolution of Epicardial Pacing Leads
28. Health Security Perceptions: Initial Psychometric Analysis of the Construct of Health Security in Chronic Illness within Cardiac Device Patients
29. Study of ECG-derived atrial fibrillatory rate for prediction of the outcome of cardioversion of short duration atrial fibrillation (CASAF)
30. Cryoballoon or Radiofrequency Ablation for Atrial Fibrillation Assessed by Continuous Monitoring: A Randomized Clinical Trial
31. Temporary active fixation lead pacemaker in transcatheter aortic valve replacement patients with right bundle branch block
32. Health Security Perceptions: Initial Psychometric Analysis of the Construct of Health Security in Chronic Illness Among Patients With a Cardiac Device
33. Effect of Baseline Antiarrhythmic Drug on Outcomes With Ablation in Ischemic Ventricular Tachycardia: A VANISH Substudy (Ventricular Tachycardia Ablation Versus Escalated Antiarrhythmic Drug Therapy in Ischemic Heart Disease)
34. Leucocyte-derived micro-RNAs as candidate biomarkers in Brugada syndrome.
35. Safety of Cefazolin Test Dose in Patients With Penicillin Allergy Just Prior to Cardiac Device Implantation: A Single-Centre Experience
36. Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients With Heart Failure and Atrial Fibrillation: Results from the RAFT-AF trial
37. Validation of Novel 3-Dimensional Electrocardiographic Mapping of Atrial Tachycardias by Invasive Mapping and Ablation: A Multicenter Study
38. Inverse Relationship Between Fractionated Electrograms and Atrial Fibrosis in Persistent Atrial Fibrillation: Combined Magnetic Resonance Imaging and High-Density Mapping
39. Abstract 21033: Effect of Baseline Antiarrhythmic Drug on Outcomes With Ablation in Ischemic Ventricular Tachycardia: A Vanish Substudy
40. When to Consider Ablation for Premature Ventricular Complexes?
41. CA-531-04 CANADIAN EXPERIENCE WITH SALINE ENHANCED RADIOFREQUENCY NEEDLE TIP ABLATION FOR VENTRICULAR TACHYCARDIA (SERF VT CANADA TRIAL)
42. Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study
43. DREAM-ICD-II Study
44. Alternating morphology ventricular tachycardia associated with stable coronary artery disease: A case report
45. Longitudinal follow-up of Riata leads reveals high annual incidence of new conductor externalization and electrical failure
46. PO-01-123 RECURRENT VT IS SLOWER IN PATIENTS TREATED WITH ESCALATED ANTIARRHYTHMIC DRUG THERAPY: INSIGHTS FROM THE VANISH TRIAL
47. Pattern of Atrial Fibrillation and Cognitive Function in Young Patients With Atrial Fibrillation and Low CHADS 2 Score: Insights From the BRAIN-AF Trial
48. Ventricular tachycardia characteristics and outcomes with catheter ablation vs. antiarrhythmic therapy: insights from the VANISH trial
49. Comparative effectiveness of ventricular tachycardia ablation vs. escalated antiarrhythmic drug therapy by location of myocardial infarction: a sub-study of the VANISH trial
50. Ambulatory Electrocardiographic Monitoring Following Minimalist Transcatheter Aortic Valve Replacement
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.